Skip to content

Pharmacy

NCPA urges House passage of PBM reform package

NCPA urges House passage of PBM reform package

ALEXANDRIA, Va.  – The National Community Pharmacists Association issued the following statement from Anne Cassity, senior vice president of government affairs, as the House of Representatives prepares to vote today on the Lower Costs, More Transparency Act (H.R.

Pharmasave launches adult immunization drive

Pharmasave launches adult immunization drive

As Canadians head into the holidays and peak respiratory virus season, Pharmasave pharmacists are urging adults to ensure they are up to date on recommended vaccinations. Those not yet protected could be putting their health and the health of those around them at risk.

HDA issues statement on drug shortages

HDA issues statement on drug shortages

Healthcare Distribution Alliance (HDA) president and CEO Chip Davis released the following statement in response to the Senate Finance Committee’s hearing on “Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective.

Lilly’s Omvoh now available in the U.S. for ulcerative colitis

Lilly’s Omvoh now available in the U.S. for ulcerative colitis

The Food and Drug Administration has approved Eli Lilly and Co.’s Omvoh (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL), as the first and only interleukin-23p19 (IL-23p19) antagonist for the treatment of moderately to severely active ulcerative colitis (UC) in adults.